Find a Study

STUDY SEARCH RESULTS

Notify Me When Search is Updated

2 studies found for your search request: 3475-587

Efficacy, Safety, and Tolerability of Gebasaxturev (V937) Administered Intravenously or Intratumoral...
Condition: Advanced/metastatic melanoma
Minimum Age: 18 years, Maximum Age: N/A
Gender: All
Study ID: NCT04152863
Status: Terminated (Halted Prematurely)
Has Results

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currentl...
Condition: Solid tumors, Hematologic malignancies
Minimum Age: 18 years, Maximum Age: N/A
Gender: All
Study ID: NCT03486873
Status: Recruiting
Has Enrolling Locations in US or Canada

Previous
1
Next

Copyright © 2025 · Merck & Co., Inc., Rahway, NJ, USA, and its affiliates. All rights reserved. · This site is intended only for residents of the United States.
Cookie Preferences Privacy Terms of Use Consumer Health Data Privacy Policy Your Privacy Choices Accessibility U.S. Corporate Site